Cargando…

Safety of rituximab in children with auto-immune diseases

Detalles Bibliográficos
Autores principales:	Bader-Meunier, B, Quartier, P, Wouters, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334062/ http://dx.doi.org/10.1186/1546-0096-6-S1-P255

Ejemplares similares

Inflammatory arthritis associated with inflammatory bowel disease in children
por: Desgranges, M, et al.
Publicado: (2008)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

Infantile Onset Panniculitis with Uveitis and Systemic Granulomatosis: immunohistochemical findings
por: Wouters, CH, et al.
Publicado: (2008)

PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis
por: Mestrallet, G, et al.
Publicado: (2013)

PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics
por: Remy Piccolo, V, et al.
Publicado: (2013)

Pediatric systemic lupus erythematosus and human parvovirus B19 infection
por: Bélien-Pallet, V, et al.
Publicado: (2011)

Diversity in clinical manifestations of autoinflammatory syndromes
por: Boiu, S, et al.
Publicado: (2011)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
por: Melki, I, et al.
Publicado: (2011)

Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients
por: De Somer, L, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Juvenile overlap myositis: retrospective study about 20 cases
por: Piccolo, Vanessa Remy, et al.
Publicado: (2014)

Emperipolesis and cell death in NOD2-related Blau Syndrome and Crohn’s disease
por: Janssen, Carl EI, et al.
Publicado: (2011)

Prescribing adrenaline auto-injectors in Slovenian children
por: Vesel, Tina, et al.
Publicado: (2015)

Efficacy of high dose methotrexate in pediatric auto-immune uveitis
por: Armbrust, Wineke, et al.
Publicado: (2014)

Clinical characteristics, management and outcomes in patients with juvenile dermatomyositis requiring admission in pediatric intensive care unit
por: Besancon, Alix, et al.
Publicado: (2014)

Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ?
por: Bader-Meunier, B, et al.
Publicado: (2011)

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)
por: Ruperto, N, et al.
Publicado: (2008)

PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to <4 years or >=4 years weighing <15 kg
por: Kingsbury, D, et al.
Publicado: (2013)

Auto immune haemolytic anaemia as part of Nevirapine induced DRESS syndrome
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Outcome of children with panarteritis nodosa: a series of 30 cases
por: Merlin, E, et al.
Publicado: (2011)

Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?
por: Jurado, C, et al.
Publicado: (2011)

The effect of Rituximab treatment on T cells
por: Diaz-Torné, C, et al.
Publicado: (2010)

Impact of biologics on growth in children with juvenile idiopathic arthritis
por: Uettwiller, F, et al.
Publicado: (2011)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Auto-antibody testing for children on biologic therapies for rheumatological conditions: results of audit
por: Duncan, Julie, et al.
Publicado: (2011)

Prescribing of adrenaline auto-injectors
por: Kahlon, Gurnaaz Kaur
Publicado: (2015)

PReS-FINAL-2301: Cardiac tamponade and auto-immune haemolysis as first presentation of JSLE
por: Yiallourides, M, et al.
Publicado: (2013)

Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab
por: Forero, Andres, et al.
Publicado: (2013)

Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
por: Ohl, Kim, et al.
Publicado: (2011)

Targeted delivery to inflammatory monocytes for efficient RNAi-mediated immuno-intervention in auto-immune arthritis
por: Présumey, Jessy, et al.
Publicado: (2011)

Use of Rituximab in child with SLE and myocardial involvement
por: Balan, S, et al.
Publicado: (2008)

P078 Predicting initial AutoPAP pressures in children - how do we perform ?
por: Mihai, R, et al.
Publicado: (2022)

International PFAPA syndrome registry: cohort of 214 patients
por: Hofer, MF, et al.
Publicado: (2008)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
por: Sacri, AS, et al.
Publicado: (2011)

Adrenaline auto-injector devices: do current prescription and training measures work?
por: Alam, S, et al.
Publicado: (2013)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus
por: Eisenberg, RA, et al.
Publicado: (2004)

Auto-recruitment of dorsal lung regions in horses after anaesthesia
por: Mosing, M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j24649v4pciglc7m31hlck6752